Company Avricore Health Inc.

AVCR

CA0545211090

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Delayed Toronto S.E. Other stock markets 03:59:59 2024-05-17 pm EDT			5-day change	1st Jan Change
0.155 ^CAD	-3.12%		0.00%	-8.82%

Apr. 30	Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 04	Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations	MT

Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.

CAD in Million	2022	Weight	2023	Weight	Delta
HealthTab - Point of Care 100.0 %	2	100.0 %	3	100.0 %	+97.08%

CAD in Million	2022	Weight	2023	Weight	Delta
Canada 100.0 %	2	100.0 %	3	100.0 %	+97.08%

Managers	Title	Age	Since
Hector Bremner CEO	Chief Executive Officer	-	18-12-31
Kiki Smith DFI	Director of Finance/CFO	-	19-08-05
Rodger Seccombe CTO	Chief Tech/Sci/R&D Officer	-	20-12-07
Mark Kunzli PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
David Hall CHM	Chairman	71	16-01-19
Robert Sindelar BRD	Director/Board Member	71	18-03-26
Christine Hrudka BRD	Director/Board Member	-	23-06-20
Rodger Seccombe CTO	Chief Tech/Sci/R&D Officer	-	20-12-07
Alan Arnstein BRD	Director/Board Member	56	17-04-19
Hector Bremner CEO	Chief Executive Officer	-	18-12-31
Thomas Teahen BRD	Director/Board Member	-	23-06-20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	99,869,664	90,194,935 ( 90.31 %)	0	90.31 %

Name	Equities	%	Valuation
Rodger Seccombe 4.477 %	4,461,111	4.477 %	450 572 $
Hector Bremner 1.495 %	1,490,000	1.495 %	150 490 $
David Hall 1.372 %	1,367,618	1.372 %	138 129 $
Kiki Smith 0.9193 %	916,000	0.9193 %	92 516 $
Robert Sindelar 0.7978 %	795,000	0.7978 %	80 295 $
David Farnfield 0.6222 %	620,000	0.6222 %	62 620 $
Alan Arnstein 0.0251 %	25,000	0.0251 %	2 525 $
Christine Hrudka 0.0226 %	22,500	0.0226 %	2 273 $
Thomas Teahen 0.000000 %	0	0.000000 %	- $

Avricore Health, Inc.

789 West Pender Street Suite 1120

V6C 1H2, Vancouver

http://www.avricorehealth.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
AVRICORE HEALTH INC.	-8.82%	11.37M
ELI LILLY AND COMPANY	+37.80%	705B
NOVO NORDISK A/S	+32.82%	583B
JOHNSON & JOHNSON	-3.59%	364B
MERCK & CO., INC.	+19.88%	332B
ABBVIE INC.	+5.24%	291B
ASTRAZENECA PLC	+16.64%	238B
ROCHE HOLDING AG	-4.13%	210B
NOVARTIS AG	+10.63%	209B
AMGEN INC.	+9.21%	169B

Other Pharmaceuticals